Agent Name
Triphenyl phosphate
Major Category
Other Classes
Synonyms
Celluflex TPP; Disflamoll TP; Phenyl phosphate ((PhO)3PO); Phosflex TPP; Phosphoric acid, triphenyl ester; TP (VAN); TPP; Trifenylfosfat [Czech]; Triphenoxyphosphine oxide; Triphenyl phosphate; Triphenylphosphate; [ChemIDplus]
Category
Organophosphates, Other
Description
Colorless, crystalline powder with a phenol-like odor; [NIOSH]
Sources/Uses
Used as a plasticizer, fire-retardant, and substitute for camphor in celluloid; also used in lubricating oils and hydraulic fluids; [ACGIH]
Comments
Cholinesterase inhibition, but no cumulative toxicity, was observed in animal studies. A study of 33 workers (employed for an average of 7.4 years) in a plant manufacturing TPP found no adverse health effects. A slight reduction in erythrocyte cholinesterase activity was found in six workers. One case of occupational allergic contact dermatitis has been documented. [ACGIH] In high-dose animal studies, adverse effects include delayed paralysis similar to that seen with tri-o-cresyl phosphate. [HSDB]
Skin Designation (ACGIH)
Insufficient data
MAK
10 mg/m3, inhalable fraction
Excerpts from Documentation for IDLHs
Human data: Workers exposed to an average air concentration of 3.5 mg/m3 for as long as ten years showed no evidence of adverse clinical effects [Sutton et al. 1960]. . . . Basis for revised IDLH: The revised IDLH for triphenyl phosphate is 1,000 mg/m3 based on acute oral toxicity data in animals [Antonyuk 1974].
Vapor Pressure
2E-06 mm Hg
Explanatory Notes
Flash point = 220 deg C; VP from HSDB;
Neurotoxin
Predominantly motor
ACGIH Carcinogen
Not Classifiable
Diseases
Occupational diseases associated with exposure to this agent: